These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5309468)

  • 1. Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.
    Schoenbaum SC; Mostow SR; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):531-5. PubMed ID: 5309468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):525-30. PubMed ID: 5309467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.
    Knight V; Couch RB; Douglas RG; Tauraso NM
    Bull World Health Organ; 1971; 45(6):767-71. PubMed ID: 5317012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Postgrad Med J; 1973 Mar; 49(569):152-8. PubMed ID: 4802501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic.
    Monto AS; Davenport FM; Napier JA; Francis T
    Bull World Health Organ; 1969; 41(3):537-42. PubMed ID: 5309469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
    Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desoxycholate-split influenza vaccines.
    Warburton MF
    Bull World Health Organ; 1969; 41(3):639-41. PubMed ID: 5309488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of influenza vaccination in prevention of influenza-like illness among inhabitants of old folk homes.
    Isahak I; Mahayiddin AA; Ismail R
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):841-8. PubMed ID: 18041300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months.
    Maeda T; Shintani Y; Nakano K; Terashima K; Yamada Y
    Pediatr Int; 2004 Apr; 46(2):122-5. PubMed ID: 15056235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine.
    Sonoguchi T
    Bull World Health Organ; 1969; 41(3):517-23. PubMed ID: 5309466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The perceptions of and disincentives for receiving influenza A (H1N1) vaccines among chronic renal disease patients in Hong Kong.
    Siu JY
    Health Soc Care Community; 2012 Mar; 20(2):137-44. PubMed ID: 21848853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
    Tsang P; Gorse GJ; Strout CB; Sperling M; Greenberg DP; Ozol-Godfrey A; DiazGranados C; Landolfi V
    Vaccine; 2014 May; 32(21):2507-17. PubMed ID: 24120672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.